Authors
Gokce Belge Bilgin, Cem Bilgin, Ephraim E Parent, Derek R Johnson
Published in
Neuroimaging clinics of North America. Volume 37. Issue 1. Pages 155-168. Epub Sep 30, 2026.
Abstract
Neuroimaging plays a central role in the management of intracranial metastatic disease (IMD), providing the foundation for diagnosis, treatment planning, and posttherapy surveillance. MR imaging has limitations in certain clinical scenarios, particularly in differentiating actual tumor progression from treatment-related changes such as radiation necrosis. Growing evidence supports the complementary role of molecular imaging, particularly amino acid PET, in providing metabolic insights that can enhance diagnostic accuracy in these complex situations in the setting of IMD. This comprehensive article examines the expanding role of molecular imaging in IMD and highlights the emerging clinical insights PET may offer to improve patient care.
PMID:
43014977
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0